According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current revenue (TTM ) is โน11.11 Billion. In 2024 the company made a revenue of โน9.01 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.